JK Rowling donates £15 million to multiple sclerosis research

JK Rowling donates £15 million to multiple sclerosis research

Writer and philanthropist J.K. Rowling has donated a whopping £15 million to the University of Edinburgh for multiple sclerosis research.

The author lost her own mother Anne to the disabling brain and spine condition when she was just 25-years-old. Anne Rowling (née Volant) died at the age of just 45, have suffered from the condition for ten years.

Although her mother heavily affected Rowling's writing, Anne would die before ever seeing her daughter become one of the most famous and successful novelists of all time.

Commenting on the donation, Rowling stated: "When the Anne Rowling Clinic was first founded, none of us could have predicted the incredible progress that would be made in the field of regenerative neurology, with the clinic leading the charge."

She continued: "It's a matter of great pride for me that the clinic has combined these lofty ambitions with practical, on the ground support and care for people with MS, regardless of stage and type; I've heard at first-hand what a difference this support can make.

Check out this amazing video of a woman who can recite the Harry Potter books from memory:

She added: "I am confident that the combination of clinical research and practical support delivered by Professor Siddharthan Chandran and his exemplary team will create a definitive step-change for people with MS and associated conditions."

Commenting on her mother's condition in a 2010 interview with The Daily Telegraph, Rowling stated: "Barely a day goes by when I do not think of her. There would be so much to tell her, impossibly much ... She was so young and so fit. To have your body in rebellion against you is a dreadful thing to witness, let alone suffer."

Take a look at this incredible Harry Potter-themed fortress: 

JK Rowling first established the Anne Rowling Regenerative Neurology Clinic at the University of Edinburgh in 2010. This new donation will help create new facilities and support research for MS, as well as for motor neurone disease (MND), Parkinson's and dementia.